Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal subarachnoid Hemorrhage
Clinical Trial Grant
Administered By
Neurology, Neurocritical Care
Awarded By
Edge Therapeutics, Inc
Start Date
March 1, 2016
End Date
March 31, 2019
Administered By
Neurology, Neurocritical Care
Awarded By
Edge Therapeutics, Inc
Start Date
March 1, 2016
End Date
March 31, 2019